Dr. Rajeev Singh Raghuvanshi is the Drugs Controller General of India (DCGI), leading the Central Drugs Standard Control Organization (CDSCO) under the Ministry of Health and Family Welfare.
He holds a Bachelor's and Master's degree from IIT-BHU, Varanasi, and a PhD from the National Institute of Immunology, New Delhi.
With over three decades of experience in the pharmaceutical industry, Dr. Raghuvanshi has held senior positions at Ranbaxy Laboratories and Dr. Reddy's Laboratories, focusing on generics, complex generics, novel drug delivery systems, and nanotechnology. He has a proven track record in establishing and advancing R&D organizations, leading initiatives in open innovation, technology licensing, and international collaborations. An inventor with multiple patents and publications.
Dr. Raghuvanshi has been recognized for his contributions to pharmaceutical sciences and regulatory affairs.